The early method of producing antibodies for treating disease like cancer and arthritis is quite costly and time consuming.

This is a serious problem, especially for the different drug companies, which led them to the idea of producing an inexpensive and faster way of producing antibodies.

A group left by Dr. George Georgiou, with the collaboration of Dr. Brent Iverson, did the approach. According to Iverson, the said approach is time saving and enables antibodies to be isolated to treat human diseases.

Factories that produce antibodies grew bacteria such as E. coli in a medium or both to form harmless bacteria. The harmless bacteria are then transfer to mammalian cells to produce a large number of antibodies. This process costs more for it takes months to produce a large number of antibodies.

In Georgiou’s antibody method, the antibody produced in the E. coli bacteria is use to attach to disease protein. During the interaction, the antibody prevents the disease protein from attacking the body.

A post-doctoral student in chemical engineering, Yariv Mazor, engineered the antibodies to PA toxin, an anthrax toxin. Together with a graduate student of chemical engineering, Van Blarcom, they used the method called APEx to identify the bacteria-bound antibodies that attach best to the PA. Then Blarcom took the bacteria grew a large member of them.

The method used by the persons involving iron in the studying the new, and fast method of producing antibodies.